Dr Mary Donnelly
MDPharmasolutions, Hertford, UK
Mary Donnelly obtained a Ph.D in Bioanalysis and Clinical Pharmacokinetics and a BSc (Hons) in Chemistry, both from the University of Glasgow. Her industrial career began as a pharmacokineticist at Beechams. She moved to GSK (then Glaxo) in 1990, to join the drug metabolism and pharmacokinetic research group, where she contributed to drug discovery projects in neuroscience, cardiovascular, respiratory and inflammatory areas. In 2001, Mary was appointed Director of Research DMPK for the Stevenage site; a department dedicated to the support of respiratory and inflammatory projects in the discovery phase. In 2003 Mary was appointed Global Project Leader for the development of novel respiratory and inflammatory products. Mary moved to MedImmune in 2008 to become a Product Development Leader of biologic assets for cardiovascular, autoimmune and respiratory disorders.
In 2010 Mary founded MDPharmasolutions, a consultancy business providing lead optimisation and early development support to BioTech and Pharma companies.
Contact Mary Donnelly